Abstract
GLOBAL MALARIA CONTROL EFFORTS DEPEND INcreasingly on artemisinin derivatives because of resistance to other antimalarial drugs. Emergence of artemisinin resistance could be devastating for individuals with malaria, unless timely detection by surveillance systems allows evaluation of new treatments and interventions to counter the spread of resistance. However, instead of drug resistance monitoring, major sponsors of malaria control programs emphasize other essential antimalarial strategies far more strongly. These sponsors understandably seek immediate public health results with proven antimalarial interventions, but rapid and widespread deployment of artemisinin derivatives, with insufficient attention to drug resistance, could undermine these gains. Developing an early warning system for resistance to artemisinin and other antimalarial drugs should be an urgent priority of malaria control programs and their sponsors.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call